Sirnaomics Showcases GalNAc-Based Liver-Targeting Platform and GalAhead™ Technology Advancements at TIDES USA 2022

Gaithersburg, Maryland and SuzhouMay 11, 2022/PR Newswire/ -- Sirnaomics Ltd. (“Company”，“Sirnaomics", Stock Code: 2257.HK) is a leading biopharmaceutical company focused on the exploration and development of RNAi therapies. Sirnaomics, Inc. announced that it will attend TIDESUSAThe latest progress of its GalNAc-liver targeting technology platform, GalAhead™ technology, and related projects was reported at the TIDES 2022 conference. TIDES 2022 will be held at the Hynes Convention Center in Boston, USA, from May 9 to 12, 2022.

Detailed Information on the Speech

Sirnaomics Chief Technology Officer Dmitry Samarsky, Ph.D., Will Present and Showcase Data Demonstrating the Efficacy of mxRNA in Primary Hepatocytes (in vitro) and Mice (in vivo). Dr. Dmitry Samarsky will also present the results of a 26-week non-human primate study using Sirnaomics' leading GalAhead™ therapeutic program candidate drug molecules targeting coagulation factor XI. Additionally, progress on other GalAhead™-based therapeutic programs will be reported.

For more information about the Sirnaomics presentation, please visit the event website.

AboutSirnaomics

Sirnaomics is an RNA therapeutics biopharmaceutical company with candidate products in preclinical and clinical stages, focusing on exploring and developing innovative drugs for the treatment of indications with unmet medical needs and significant market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics biopharmaceutical company to hold a strong market position in both China and the United States, and it is also the first company to achieve positive Phase IIa clinical results with its core product STP705, an RNAi therapy in the field of oncology. For more information about the company, please visit:www.sirnaomics.com。

Contact Information

Investor Relations:
Ye Yongji
CFO of Sirnaomics China
Email:NigelYip@sirnaomics.com

U.S. Media Inquiry:
Alexis Feinberg
Phone: +1 203 939 2225
Email:Alexis.Feinberg@westwicke.com

Asian Media Inquiry:
Li Yaorong
Phone: +852 3150 6707
Email:sirnaomics.hk@pordahavas.com